196 related articles for article (PubMed ID: 36054612)
21. Investigation of the Relationship among Cortisol, Pro-inflammatory Cytokines, and the Degradation of Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior.
Messaoud A; Rym M; Wahiba D; Neffati F; Najjar MF; Gobbi G; Manchia M; Valtorta F; Lotfi G; Comai S
Curr Top Med Chem; 2022; 22(25):2119-2125. PubMed ID: 34503408
[TBL] [Abstract][Full Text] [Related]
22. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.
van den Ameele S; van Nuijs AL; Lai FY; Schuermans J; Verkerk R; van Diermen L; Coppens V; Fransen E; de Boer P; Timmers M; Sabbe B; Morrens M
Bipolar Disord; 2020 Feb; 22(1):59-69. PubMed ID: 31398273
[TBL] [Abstract][Full Text] [Related]
23. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
[TBL] [Abstract][Full Text] [Related]
24. Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder.
Lin P; Li D; Shi Y; Li Q; Guo X; Dong K; Chen Q; Lou X; Li Z; Li P; Jin W; Chen S; Sun Y; Sun J; Cheng X
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049591
[TBL] [Abstract][Full Text] [Related]
25. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
[TBL] [Abstract][Full Text] [Related]
26. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
27. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis.
Hunt C; Macedo E Cordeiro T; Suchting R; de Dios C; Cuellar Leal VA; Soares JC; Dantzer R; Teixeira AL; Selvaraj S
Neurosci Biobehav Rev; 2020 Nov; 118():514-523. PubMed ID: 32853625
[TBL] [Abstract][Full Text] [Related]
28. The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.
Gabbay V; Liebes L; Katz Y; Liu S; Mendoza S; Babb JS; Klein RG; Gonen O
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):37-44. PubMed ID: 19778568
[TBL] [Abstract][Full Text] [Related]
29. Kynurenine pathway changes in late-life depression.
Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
[TBL] [Abstract][Full Text] [Related]
30. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
[TBL] [Abstract][Full Text] [Related]
31. Peripheral and central kynurenine pathway abnormalities in major depression.
Paul ER; Schwieler L; Erhardt S; Boda S; Trepci A; Kämpe R; Asratian A; Holm L; Yngve A; Dantzer R; Heilig M; Hamilton JP; Samuelsson M
Brain Behav Immun; 2022 Mar; 101():136-145. PubMed ID: 34999196
[TBL] [Abstract][Full Text] [Related]
32. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression.
Comai S; Melloni E; Lorenzi C; Bollettini I; Vai B; Zanardi R; Colombo C; Valtorta F; Benedetti F; Poletti S
Eur Neuropsychopharmacol; 2022 Feb; 55():96-109. PubMed ID: 34847455
[TBL] [Abstract][Full Text] [Related]
33. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
35. The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
Milaneschi Y; Allers KA; Beekman ATF; Giltay EJ; Keller S; Schoevers RA; Süssmuth SD; Niessen HG; Penninx BWJH
Brain Behav Immun; 2021 Oct; 97():167-175. PubMed ID: 34252568
[TBL] [Abstract][Full Text] [Related]
36. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
[TBL] [Abstract][Full Text] [Related]
37. Tryptophan Intake and Metabolism in Older Adults with Mood Disorders.
Chojnacki C; Popławski T; Chojnacki J; Fila M; Konrad P; Blasiak J
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081001
[TBL] [Abstract][Full Text] [Related]
38. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
Fujigaki H; Yamamoto Y; Saito K
Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
[TBL] [Abstract][Full Text] [Related]
40. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
